The OncoCount test is used as part of the interim monitoring mechanism to check for the efficacy of your cancer treatment. It can be used to detect the presence or recurrence of all types of cancers except those originating in the central nervous system.
Once cancer treatment has begun, we advise patients to use the OncoCount test for interim monitoring to check how their treatment is working.
If the OncoCount result shows high CTC numbers, it can mean the treatment has been ineffective, and a change is necessary. On the other hand, a substantially lower CTC count will mean that the treatment has been effective in reducing the tumor, and treatment protocols can continue.
Additionally, in cases where the reduction in the CTC count is less than expected, it can mean that the treatment needs some fine-tuning. Also, additional therapies can be added to modify your treatment plan.
We offer a whole host of additional CTC tests for more specific monitoring for treatment effectiveness and early detection in case of recurring cancer.
We recommend that patients retake monitoring tests, such as OncoCount, every 3 months as long as the cancer is active to assess the effectiveness of the treatment protocol. The monitoring can change to every 6 months once patients go into full remission and the first 2-3 follow-up tests show the condition as stable.